suma/fatigue

FIELD OF THE INVENTION This invention relates to methods of treatment of the symptoms of Chronic Fatigue Syndrome (CFS), also known as Chronic Fatigue Immune Dysfunction Syndrome (CFIDS), and Acquired Immune Deficiency Syndrome (AIDS), and compositions useful in the performance of such methods. In

The present invention relates to the use of alpha-1-antitrypsin for the preparation of effective drugs for the treatment of chronic fatigue syndrome. BACKGROUND Chronic fatigue syndrome (CFS) is a complex disorder, defined by the international Fukuda criteria (Fukuda K, et al., The chronic fatigue

TECHNICAL FIELD The present invention relates to the field of ergonomic and safety anti-fatigue matting. BACKGROUND OF THE INVENTION Work-related musculoskeletal disorders (MSD) result when there is a mismatch between the physical capacity of workers and the demands of the job. Musculoskeletal

By distinguishing between self and non-self, the immune system mediates the individual's relationship with his or her environment. When the immune system is working properly, it protects the organism from infection; when it is not, the failures of the immune system can result in some of the most

INCORPORATION BY REFERENCE TO ANY PRIORITY APPLICATIONS Any and all applications for which a foreign or domestic priority claim is identified in the Application Data Sheet as filed with the present application are hereby incorporated by reference under 37 CFR 1.57. BACKGROUND 1. Field of the

BACKGROUND OF THE INVENTION The present invention relates to an amino acid-trehalose composition developed on the basis of the knowledge obtained from a study of a composition which comprises amino acids contained in the saliva secreted by the larvae of a hornet (belonging to the genus Vespa) and

FIELD OF THE INVENTION The present invention relates to systems and methods for utilizing theacrine alone and in combination for use in providing physiological benefits. More particularly, the invention relates to theacrine and other naturally occurring compounds, whether produced synthetically or

FIELD OF THE INVENTION This invention pertains, in general, to the field of nutritional-dietary/herbal-botanical, neuro-support factors designed or intended for the sustenance of optimal healthy mental cognition. In particular, the present invention provides formulas for producing compositions for

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for testing mentation of humans, and a mentation test apparatus. More specifically, the present invention relates to a highly reproducible and reliable mentation test method that is able to sensitively

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for testing mentation of humans, and a mentation test apparatus. More specifically, the present invention relates to a highly reproducible and reliable mentation test method that is able to sensitively

The present invention is related to modified and stabilized synthetic cis-1,4polyisoprene and a process of producing same. This type of rubber is applicable to the tyre production of tires, as well as the production of rubber footwear and other articles, cable insulation, etc. At present, the

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a support for a lithographic printing plate and a presensitized plate. More particularly, the present invention relates to a presensitized plate excellent in printing performance (for example, press life, scum

BACKGROUND OF THE INVENTION 1. Field of the Invention The subject invention generally pertains to a method of identifying allergens and other influencing agents that may cause a reaction in an individual and more specifically pertains to a software program for carrying out the method. 2. Description

FIELD OF THE INVENTION The invention relates to monocrystalline alloys with a matrix having a nickel base, without the intentional addition of carbon, or boron or of zirconium. SUMMARY OF THE PRIOR ART Such alloys are known for example from FR-A-2 557 598 or from European published application

CROSS-REFERENCE TO RELATED APPLICATIONS This application claims the benefit under 35 U.S.C. .sctn.119(a) of Danish Application No. PA 2013 00427, filed Jul. 14, 2013, entitled Novel Bioactive Alkaloids and Alkaloid Fractions Derivable From Ribes Species, the disclosure of which is incorporated by